𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of serine protease inhibitors on the expression of cell surface and soluble forms of two types of tumor necrosis factor receptors

✍ Scribed by É. Pócsik; K. Szabó; P. Wirth; B.B. Aggarwal

Book ID
108409055
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
189 KB
Volume
56
Category
Article
ISSN
0165-2478

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination benefit of treatment with th
Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis
✍ Alison M. Bendele; Elizabeth S. Chlipala; Jon Scherrer; Janet Frazier; Gina Senn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 695 KB

Objective. To determine the potential for additive or synergistic effects of combination therapy with the recombinant anticytokine agents interleukin-1 receptor antagonist (IL-1Ra) and PEGylated soluble tumor necrosis factor receptor type I (PEG sTNFRI) in established type II collagen-induced arthri

Two inhibitors of pro-inflammatory cytok
Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes
✍ David A. Joyce; Deena P. Gibbons; Patricia Green; James H. Steer; Marc Feldmann; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 826 KB

## Two inhibitors of pro-inflammatory cytokine -release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes \* The biological activity of the pro-inflammatory cytokine, tumor necrosis factor (TNF)-a depends on

Cell surface expression of TNFRI in tumo
Cell surface expression of TNFRI in tumor necrosis factor receptor–associated periodic syndrome: Comment on the article by Nedjai et al
✍ Ian Todd; Patrick Tighe; Susana Rebelo; Richard Powell 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 2 views

evidence that adequate antibiotic therapy eventually eradicates Borrelia even from poorly accessible sites such as synovium. Paradoxically, in the recent Infectious Diseases Society of America guidelines on the treatment of Lyme disease (2), a single-dose antibiotic strategy for preventing Lyme dise

Expression of type a and b tumor necrosi
Expression of type a and b tumor necrosis factor (TNF) receptors on melanoma cells can be regulated by dbc-AMP and IFN-γ
✍ Stefan Carrel; Françoise Hartmann; Suzanne Salvi; Hugo Albrecht; Magali Schreyer 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 966 KB

Local administration of high-dose r-TNFa with IFNy in the limbs of melanoma patients has proved to be a very promising treatment. To understand the role played by the effect of TNF on melanoma cells in tumor destruction, we have investigated the expression of TNF-receptors in melanoma cells using mo